Hi there

Who we are

Canaan is an early-stage venture capital firm that invests in visionaries with transformative ideas.

More about us

Experience

A fine
balance

The passion you want at your side, plus the experience you want at the table.

Meet Our Team

Team

Greater perspectives create greater outcomes.

Balance, diversity and passion are at the core of who we are. Meet the hardworking people who defy convention, shatter glass ceilings, and take companies to the top—all with a unique style and a healthy dose of humor.

Companies

A dynamic
portfolio

Across healthcare and technology, we partner with companies that improve lives.

See Our Companies

Companeis

The future looks bright.

Say hello to our extended family. An impressive roster of agile and imaginative companies that are building the future of healthcare and technology, one big idea at a time. Our portfolio of entrepreneurial muscle includes 59 IPOs and 134 M&As. And counting.

Approach

A hand
in every stage

From the first handshake to the final round, we do what it takes to bring your vision to life.

Learn About Our Approach

About

This is Canaan.

Canaan is an early-stage venture capital firm that invests in visionaries with transformative ideas. While we love speedy success, we’re acutely aware that greatness comes in many forms and at different times. That’s why we’re not afraid to break the mold to bring something spectacular to life.

Hi there

Who we are

>Astra

Canaan is an early-stage venture capital firm that invests in visionaries with transformative ideas.

More about us

Experience

A fine
balance

>The RealReal

The passion you want at your side, plus the experience you want at the table.

Meet Our Team

Companies

A dynamic
portfolio

>IDEAYA Biosciences

Across healthcare and technology, we partner with companies that improve lives.

See Our Companies

Approach

A hand
in every stage

>Berkshire Grey

From the first handshake to the final round, we do what it takes to bring your vision to life.

Learn About Our Approach
Highlight

CNBC: Tomorrow.io Aims to Revolutionize Forecasting with a Constellation of Radar Satellites

The company recently launched Tomorrow-R1 via SpaceX’s Falcon 9 rocket.
Highlight

Snyk Named to CNBC 2023 Disruptor 50 List

Snyk has been named to the CNBC 2023 Disruptor 50 List, following its debut on the Disruptor List in 2021 and its listing as a Top Startup for the...
Highlight

BioWorld Insider Podcast: Better Times Ahead for the Biopharma Sector? Could be, the New Numbers Say

Looking at first quarter numbers and surveying the big picture on this BioWorld Insider podcast are Karen Carey, BioWorld’s managing editor and...
Highlight

MedCity News: Canaan-Backed Biotech Gives Orphan Receptor a Home and New Role in Gut Cancer Drugs

ThirtyFIveBio aims to treat gastrointestinal cancer by targeting a so-called orphan receptor called GPR35.